In a particular embodiment, said antibody is selected from the group consisting of a murine antibody, a chimeric antibody, a humanized antibody, and a human antibody.
This antibody may be a human antibody.
This antibody can be a monoclonal antibody.
The antibody composition preferably contains bifunctional antibodies or tetrameric antibody complexes.
More particularly, the isolated monoclonal antibody is selected from the group consisting of a murine antibody, a chimeric antibody, a humanized antibody, and a human antibody.
Immunoglobulin molecules include monovalent single chain antibodies, multivalent single chain antibodies, diabodies, triabodies, antibodies, humanized antibodies and chimerized antibodies.
The two other types of antibody are an immobilized antibody (Akimm) and a suitably marked antibody (Ak*) against the antigen (Ag).
Said antibody and antibodies being capable of binding to the at least one antigen.
Preferably, the antibodies used are anti-peptide antibodies.
Proteins of interest include antibodies such as single chain antibodies, single chain antibodies, and Fab fragments of antibodies or peptides such as non-antibody peptides.
The antibodies can be, for example, entirely human antibodies, recombinant antibodies, or monoclonal antibodies.
The monospecific antibodies include monoclonal antibodies and monospecific polyclonal antibodies.
The antibodies can be, for example, entirely human antibodies, recombinant antibodies, or monoclonal antibodies.
The present invention provides antibodies (e.g., monoclonal antibodies, human antibodies, humanized antibodies, etc.), which bind to multiple influenza strains.
These antibodies may be for example, hamster antibodies, chimeric human/hamster antibodies, or humanized antibodies.
These antibodies may be for example, hamster antibodies, chimeric human/hamster antibodies, or humanized antibodies.
Particular antibodies provided herein include human monoclonal antibodies.
Transport and network layer header information is collected from packet traffic in a network.
The anti-nuclease antibodies of the present invention may be a polyclonal or monoclonal antibodies, and may be antiribonuclease antibodies, anti-deoxyribonuclease antibodies, or antibodies to a non-specific nucleases.
The antibodies include polyclonal and monoclonal antibodies.
Preferred are non-activating antibodies.
These antibodies may be for example, hamster antibodies, chimeric human/hamster antibodies, or humanized antibodies.
The antibodies are different from anti-filaggrin antibodies.
Antibodies include monoclonal antibodies, humanized antibodies and functional fragments thereof.
The antibodies include murine, chimeric, and humanized antibodies
Requêtes fréquentes français :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Requêtes fréquentes anglais :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Traduction Translation Traducción Übersetzung Tradução Traduzione Traducere Vertaling Tłumaczenie Mετάφραση Oversættelse Översättning Käännös Aistriúchán Traduzzjoni Prevajanje Vertimas Tõlge Preklad Fordítás Tulkojumi Превод Překlad Prijevod 翻訳 번역 翻译 Перевод